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A B S T R A C T
Background
Cancer-related pain is complex andmulti-dimensional but themainstay of cancer painmanagement has predominately used a biomedical
approach. There is a need for non-pharmacological and innovative approaches. Transcutaneous Electric Nerve Stimulation (TENS)
may have a role for a significant number of patients but the effectiveness of TENS is currently unknown.
Objectives
The aim of this systematic review was to determine the effectiveness of TENS for cancer-related pain in adults.
Search strategy
We searched The Cochrane Library, MEDLINE, EMBASE, CINAHL, PsychINFO, AMED and PEDRO databases (11/04/08).
Selection criteria
Only randomised controlled trials (RCTS) investigating the use of TENS for the management of cancer-related pain in adults were
included.
Data collection and analysis
The search strategy identified 37 possible published studies which were divided between two pairs of review authors that decided on
study selection. A study eligibility form was used to screen each abstract and where study eligibility could not be determined from
the abstract, the full paper was obtained and assessed by one pair of review authors. A standardised data extraction sheet was used to
collect information on the studies and the quality of the studies was assessed independently by two review authors using the validated
five-point Oxford Quality Scale. Final scores were discussed and agreed between all four review authors. The small sample sizes and
differences in patient study populations of the two included studies prevented meta-analysis.
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Main results
Only two RCTs met the eligibility criteria (64 participants). These studies were heterogenous with respect to study population, sample
size, study design, methodological quality, mode of TENS, treatment duration, method of administration and outcome measures used.
In one RCT, there were no significant differences between TENS and placebo in women with chronic pain secondary to breast cancer
treatment. In the other RCT, there were no significant differences between acupuncture-type TENS and sham in palliative care patients;
this study was underpowered.
Authors’ conclusions
The results of this systematic review are inconclusive due to a lack of suitable RCTs. Large multi-centre RCTs are required to assess the
value of TENS in the management of cancer-related pain in adults.
P L A I N L A N G U A G E S U M M A R Y
Transcutaneous electrical nerve stimulation (TENS) for cancer-related pain in adults
Cancer-related pain is complex and multidimensional but is mostly managed using drug therapy. There is increasing recognition of the
need for non-drug approaches and TENS may have a significant role to play. Only two studies met eligibility criteria for this review.
TENS was given to five participants in one study and 41 participants in the other. Consequently, there is insufficient evidence to
judge whether TENS should be used in adults with cancer-related pain. Further research using well designed clinical trials is needed to
improve knowledge in this field.
B A C K G R O U N D
There are many reasons why a patient with cancer may experience
pain and these include pain associated with the disease, pain as-
sociated with the cancer treatments and any associated co-morbid
conditions. The mainstay of cancer pain management has pre-
dominantly used the biomedical approach including drug ther-
apy, medical or surgical treatments (Turk 1998). However, it is
clear that cancer-related pain is complex and multidimensional
and there is a definite need for amulti-disciplinary team approach,
utilising non-pharmacological and innovative approaches. Physi-
cal treatments such as electrical stimulation may have a role for a
significant number of patients (Simpson 2000).
Transcutaneous electrical nerve stimulation (TENS) is a non-in-
vasive therapeutic intervention which has been widely used for
many years to manage a range of acute and chronic pain prob-
lems (Johnson 2002; Walsh 1997). TENS is used in a variety
of clinical settings and has gained popularity with both patients
and healthcare professionals of different disciplines. TENS devices
have many advantages in that they are portable, easy to use, have
relatively few side-effects or contra-indications and allow the user
autonomy over their pain control.
There are several types of TENS application which are used in
clinical practice but the twomost common are high frequency, low
intensity (conventional) TENS (LF-TENS) and low frequency,
high intensity (acupuncture-like) TENS (AL-TENS).More recent
developments of TENS have evolved with the aim of improving
the efficacy of TENS and these include ’burst’ and ’modulated’
modes of stimulation. The clinical use of conventional TENS is
underpinned by the gate control theory of pain (Melzack 1965)
which suggests that there is a ’gating’mechanism in the dorsal horn
of the spinal cord which can control nociceptive signals and ulti-
mately influence the pain experience. In summary, the stimulation
of large diameter (A-beta) afferent fibres is thought to ’close the
gate’ and reduce the perception of pain. Acupuncture-like TENS
mainly stimulates A-delta and C fibres and is therefore thought
to achieve pain control mostly through the descending pain sup-
pression system. In essence, acupuncture-like TENS is thought to
help close the gateway of pain transmission and hence result in a
reduction in pain.
There are currently five Cochrane Systematic Reviews addressing
the use of TENS for benign pain (Brosseau 2003; Carroll 2001;
Khadilkar 2005; Osiri 2000; Proctor 2005) as well as excellent
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review articles (Bjordal 2003; Johnson 2001; Reeve 1996). There
is some controversy over the use of TENS in chronic pain, with
most review papers citing the need for further research using large
multi-centre RCTs. The single available review in cancer pain ad-
dresses non-drug approaches for symptoms related to cancer and
includes the evidence on TENS for painmanagement (Pan 2000).
Although experts in the field suggest that TENS has an important
role in the management of cancer-related pain (Filshie 2000) it is
clear that there is currently no guidance for clinicians on the use
of TENS for oncology and palliative care patients. The clinical
benefit of TENS for cancer patients with pain remains controver-
sial. A Cochrane review of TENS in acute pain is currently being
undertaken (Walsh 2006).
The aim of this Cochrane review is to determine the effectiveness
of TENS in themanagement of cancer-related pain and to provide
guidance for healthcare professionals and patients on the optimal
parameters of TENS for best pain relief.
O B J E C T I V E S
To establish the effectiveness of TENS in the management of can-
cer-related pain in adults.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Only randomised controlled trials (RCTs) (crossover and parallel
design) were included; those investigating the use of TENS for the
management of cancer-related pain in adults where the control
(placebo) group was clearly defined and was either:
1. no active stimulation or,
2. no treatment.
Comparisons of TENS with active treatment were not included.
Types of participants
Participants were 18 years of age or older. They had experienced
cancer-related pain, unspecified or persistent cancer treatment-re-
lated pain, or both, for a minimum of three months after any anti-
cancer treatment had been completed. Pain was classified based
on commonly used verbal rating scales or pain interference scales.
Types of interventions
Only studies that evaluated transcutaneous electrical stimula-
tion administered using a standard TENS device that delivered
monophasic or biphasic pulsed electrical currents in the mA range
were included. Studies that used percutaneous electrical stimula-
tion were not included. We considered Conventional TENS as
administered using any TENS device which delivered a “strong
but comfortable” electrical sensation either:
i. in an area of pain where sensation is present,
ii. over nerve bundles proximal to the site of pain.
Our definition of appropriate TENS delivery also included the use
of Neuromuscular Electrical Stimulation devices (NMES) and In-
terferential current devices, providing that a “strong but comfort-
able” electrical sensation was produced. Any parameters of treat-
ment which resulted in this were considered, as was any duration
and frequency of treatment. TENS is typically delivered using
at least two surface electrodes; however, studies involving single
electrical probes (i.e. TENS pens) were also included providing
that a “strong but comfortable” electrical sensation was produced.
This included the placement of electrodes over an area of pain
that co-incidentally included acupuncture points. Given the above
physiological criteria, TENS delivered at intensities reported to be
“barely perceptible” or “mild” were excluded.
Types of outcome measures
The primary outcome measure was patient reported pain using
validated scales (e.g. visual analogue scales (VAS), numerical rating




• range of movement,





• hospital attendance and other healthcare interventions e.g.
physiotherapy visits, hospice admissions, and
• adverse events - major and minor.
Ideally, studies would take outcome measures before, during and
after stimulation but studies which did not do this were not ex-
cluded. We wanted to perform subgroup analyses on outcomes of
greater than or equal to 30% reduction in pain from baseline but
this was not possible.
Search methods for identification of studies
The Cochrane Library, MEDLINE, EMBASE, CINAHL, Psych-
INFO, AMED and PEDRO physiotherapy databases were
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searched on the 11th of April 2008. Detailed search strategies
were developed for each database searched, based on the strategy
for MEDLINE but revised appropriately for each database. Vari-
ous foreign language databases were also searched with the terms
outlined below. Reference lists of eligible trials were reviewed to
identify further studies. Relevant RCTs were identified using the
following search strategy combined with the Cochrane Sensitive
Search Strategy for RCTs {as published in Appendix 5b in the
Cochrane Reviewers’Handbook for Systematic Reviews (Alderson
2004)}. Our MEDLINE search strategy for this review can be
seen in Appendix 1 and all other search strategies can be seen in
Appendix 2.
Data collection and analysis
Study selection
The search strategy identified 36 published studies which were di-
vided between twopairs of review authors that decided on study se-
lection. An additional seven published studies that were not iden-
tified by the search strategy were identified from reference lists and
contact with authors. A study eligibility form was used to screen
each abstract which identified whether the study was randomised,
participants were adults with cancer related pain, the study com-
pared TENS with another control group, and reported pain re-
lated outcomes. Where study eligibility could not be determined
from the abstract, the full paper was obtained and assessed by one
pair of review authors.
Data extraction
A standardised data extraction sheet was used to collect informa-
tion on authors, participants, trial design, characteristics of inter-
ventions (TENS settings, application, treatment schedule, concur-
rent interventions), adverse effects and baseline and end of study
outcomes. The quality of the studies was assessed independently
by two review authors using the validated five-point Oxford Qual-
ity Scale (Jadad 1996) which considers the method of randomi-
sation, blinding and the description of withdrawals or drop-outs.
KR was not involved in this process as one of her publications was
assessed. Final scores were discussed and agreed between all four
review authors.
Analysis
The small sample sizes and differences in patient study populations
of the two included studies prevented meta-analysis.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
In total 43 published studies were identified, of which only two
met our eligibility criteria for review (Gadsby 1997; Robb 2007).
The most common reasons for exclusion were non-randomised
studies and the published source contained no clinical data (i.e.
educational reviews). A full list of the 41 excluded studies and the
reasons for exclusion is provided in the ’Characteristics of excluded
studies’ table.
The two RCTs included in our review were heterogenous with
respect to study population, sample size, study design, method-
ological quality, mode of TENS, treatment duration, method of
administration and outcome measures used (Gadsby 1997; Robb
2007). Participants who had previously used TENSwere excluded
in both studies. Robb 2007, who is also a member of this review
team, compared conventional TENS with Transcutaneous Spinal
Electroanalgesia (TSE) and sham TSE in 49 cancer survivors with
chronic pain associated with breast cancer treatment. The inves-
tigators attempted to mimic clinical practice and used treatment
for three weeks duration of each intervention with participants
also self-treating at home as needed. They assessed outcome using
measures for pain, anxiety and depression and physical function-
ing. Gadsby 1997 investigated acupuncture-like TENS for cancer
pain or nausea and vomiting, or both, in 15 terminally ill par-
ticipants. The investigators administered TENS for 30 minutes
daily for five days and assessed the outcome using a quality of life
questionnaire and a performance status score (see ’Characteristics
of included studies’ table for more details).
Risk of bias in included studies
Robb 2007 scored four points and Gadsby 1997 scored three
points on the five-point Oxford Quality Scale (Jadad 1996).
Effects of interventions
Robb 2007 found no significant differences in pain relief scores
betweenTENS or shamTSE. There were also no significant differ-
ences in any of the other outcome measures, except one dimension
of a patient satisfaction questionnaire where TENS was consid-
ered significantly more effective than sham TSE. Twenty six of 41
women (63%) who completed the study decided to continue with
a device on completion of the trial and of these, the majority (n =
13) decided to continue with TENS, as opposed to shamTSE (n =
six). The majority of the women continuing with TENS were still
using it to good effect at three months (n = 14) and 12 months (n
= ten), with those using sham TSE to good effect at three months
and 12 months, n = four and n = two respectively. Overall, TENS
appeared to be well tolerated, women found TENS easy to use and
few reported difficulties with electrode placement. Adverse effects
were monitored and reported and were minimal in this study.
Gadsby 1997 did not detect any statistically significant differences
between AL-TENS and sham AL-TENS. However, the study was
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underpowered with only five participants randomised into each of
the three treatment groups and only 13 participants completing
the study.
D I S C U S S I O N
The results of this systematic review examining the effectiveness
of TENS for cancer pain in adults are inconclusive due to a lack of
suitableRCTs.Only twoRCTsmet the inclusion criteria for review
and heterogeneity of these RCTs prevented meta-analysis. The
studieswere differentwith respect to study population, sample size,
study design, methodological quality, mode of TENS, treatment
duration, method of administration and outcome measures used.
The larger study (Robb 2007) scored four out of five for theOxford
Quality Score and provided little evidence that TENSwas superior
to a placebo in treating women with chronic pain following breast
cancer treatment. The smaller study (Gadsby 1997) scored three
out of five and provided no evidence that TENS was significantly
better than placebo in treating pain in palliative care patients. We
are unable to comment on important clinical issues such as optimal
treatment parameters as there was insufficient data for analysis.
There have beennoprevious systematic reviews onTENS in cancer
pain and only one review paper has been published (Pan 2000).
This paper reviewed the use of complementary and alternative
medicine tomanage pain and other symptoms associated with end
of life. Four studies on TENS were discussed (Avellanosa 1982;
Gadsby 1997; Ostrowski 1979 and Wen 1977), one of which was
included in our review (Gadsby 1997). Pan 2000 concluded that
TENS, along with a range of other interventions, may provide
pain relief in palliative patients with pain but acknowledged that
there is a paucity of data to support this. A major criticism of the
majority of studies found in the literature search is that they were
mostly case-series or non-randomised studies and the bulk of these
studies were published in the 1970s and 1980s.
A major criticism of both RCTs found in the literature search is
that they were undersized and lacked sufficient power to detect
significant differences. Robb 2007 performed power calculations
but failed to recruit a sufficient number of participants whereas
Gadsby 1997 did not perform any power calculations. Adequate
blinding was an issue in both studies with Robb 2007 failing to
blind the assessor and Gadsby 1997 failing to provide sufficient
information on how blinding was performed.
In summary, there is insufficient evidence to judge whether TENS
should be used in adults with cancer-related pain. Further research
is needed to improve knowledge in this field.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The evidence from two RCTs provides insufficient evidence to
judge whether TENS should be used to manage cancer-related
and cancer treatment-related pain.
Implications for research
Large multi-centre RCTs are required to assess the value of TENS
in the management of cancer-related pain. Attention should be
given to:
• power calculations to ensure adequate sample sizes;
• selection of participants to ensure homogeneity of pain
conditions under study;
• optimal stimulation parameters and treatment schedules;
• use of valid, reliable outcome measures to assess all
dimensions of pain;
• short and long-term follow-ups; and
• cost analysis in comparison to standard treatment i.e.
medications.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Gadsby 1997
Methods Double-blind RCT.
Participants were allocated to active AL-TENS (Gp 1), placebo AL-TENS (Gp 2) or no treatment (Gp
3).
Sample size: total 15 were randomised (Gp 1 n=5; Gp 2 n= 3; Gp 3 n=5).
Follow-up: none.
TENS administered by nurse practitioner (author).
Outcome measures at baseline and on day 6. Retrospective analysis of analgesic and anti-emetic use on
day 6. Daily biophysical measurements of body electrical resistance.
No reporting of adverse effects.
Participants Inclusions: admitted for symptom control; aged between 35-75; pain and/or nausea and vomiting symp-
toms; Caucasian origin.
Exclusions: unwilling to provide informed consent; too ill to cope with 30 mins treatment; patients with
an on-demand pacemaker, premenopausal women, patients with vomiting due to intestinal obstruction
or raised intracranial pressure or iatrogenic causes, patients previously treated with TENS or AL-TENS.
Gender: 14 females, 1 male. Age range 38-74 years. All terminal cancer; diagnoses: Breast (n=6), Colon
(n=3), Pancreas (n=2), Stomach (n=1), Cervical (n=1).
Dropouts: n=2; both in placebo group, due to a rapid deterioration in their condition.
Interventions AL-TENS and placebo delivered via 2 gelled carbon electrodes, sealed with tape: one to acupuncture point
Pe6 (Neiguan) and one to L14 (Hegu) of dominant hand. Leads attached to V-TENS stimulator.
Electrical parameters: pulse rate: 2 Hz, symmetrical biphasic pulsewave in continuous mode; pulse width:
200 ms; amplitude: 2.5.
Duration of treatment: 30 minutes; frequency: 5/day.
Outcomes EORTC QOL-C30 at baseline and on Day 6. Includes dimensions on pain, nausea and vomiting and
fatigue, global quality of life and 5 functional scales.
Retrospective assessment of analgesic and anti-emetic use over study period at Day 6.
Notes Quality: 3
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
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Robb 2007
Methods Randomised, placebo-controlled crossover trial design.
Participants stratified according to level of average pain prior to randomisation.
Randomised to 1 of 6 groups for TENS, TSE and placebo TSE.
Sample size: total 49 were randomised (group 1: 9; group 2: 6; group 3: 9; group 4: 10; group 5: 7; group
6: 8).
Treatment duration: 3 weeks of each treatment (12 weeks) with 3 x 1 week breaks in between treatments.
Follow-up: 3, 6 and 12 months.
TENS administered by researcher in clinic and taught to subjects to use at home.
Self-report pain and mood questionnaires completed at baseline then weekly thereafter during interven-
tion, then at 3, 6 and 12 months.
Pain diaries completed daily during intervention.
Objective measures of shoulder mobility completed by researcher at baseline and at the end of every arm
of the trial.
Self-report satisfaction questionnaire on completion of the trial.
Participants Inclusions: history of breast cancer and chronic pain for at least 6 months due to cancer treatment.
Exclusions: under 18 years of age, evidence of recurrent disease, cognitive deficits, pain due to a neurological
deficit, absence of skin sensation in the painful area, previous experience of TENS.
Gender: all female.
50% had pain secondary to surgery, 20% has pain secondary to radiotherapy, 30% had a combination.
Mean age: 58 years (med: 59 range: 38-60).
Mean duration of pain: 51 months (med: 31 range: 6-182).
Majority were Caucasian (87%), married (61%) and in employment (44%).
Dropouts: n=8 (pain increased: n=2; pain resolved: n=2; skin reaction: n=1; other: n=3).
Interventions Concurrent treatment: subjects permitted to continue with all current medications but not permitted to
start any new treatments during the trial.
TENS: dual channel stimulator with self-adhesive pads (Spembly Medical Ltd). Amplitude adjusted to
provide a “strong but comfortable” tingling sensation. Continuous mode. Pulse width: unknown. Pulse
frequency: high (subject adjusted according to comfort). Electrode placement: in area of pain or adjacent
dermatome. Two or four electrodes according to size of area. Treatment schedule: as determined by subject,
advised on > 1 hour duration, frequency: as determined by pain.
TSE: single channel stimulatorwith self-adhesive pads (AdvancedPainManagement Ltd). Pulse frequency:
2000 Hz. Electrode placement: 2 pads para-vertebrally at C3-4 level for pain in the neck, arm or hand.
Two pads over spinous processes of T1 and T10 for all pain below the neck. Treatment duration: 10-30
minutes, frequency: as determined by pain.
Placebo: procedure as for TSE.
Outcomes Brief Pain Inventory (BPI) short form: measured at baseline then weekly thereafter whilst receiving treat-
ment. Post-treatment measurement at 3, 6 and 12 months.
Hospital Anxiety and Depression Scale (HAD): measured as above.
Range of movement at the ipsilateral shoulder joint (flexion and abduction): measured with a goniometer
at baseline and at the end of each intervention.
Pain diaries documented daily by the subjects: pain relief and analgesic consumption.
Patient satisfaction questionnaire to evaluate satisfaction with each treatment: recorded on completion of
the trial.
Adverse effects like skin irritation and increased pain were monitored throughout.
Notes Quality: 4
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Robb 2007 (Continued)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
RCT: Randomised Controlled Trial
Gp: group
n: number
TENS: Transcutaneous electrical nerve stimulation
AL-TENS: Acupuncture-like TENS




C3-4: cervical spine level 3-4
T1: thoracic spine level 1
T10: thoracic spine level 10
EORTC QOL-C30: European organisation for research and treatment of cancer quality of life questionnaire
Characteristics of excluded studies [ordered by study ID]
Avellanosa 1982 Non-randomised study
Bild 1990 Non-randomised study
Bonakdar 2004 No clinical data
Cata 2004 Non-randomised study
Cooperman 1975 Non-randomised study, not cancer-related pain
Crompton 1992 Non-randomised study, not cancer-related pain
De-Pinto 2006 No clinical data
Dil’Din 1985 Non-randomised study
Evtiukhin 1998 Non-randomised study
Hakl 1989 Non-randomised study
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(Continued)
Hamza 1999 Not cancer-related pain
Hasun 1988 Non-randomised study
Hidderley 1997 Cancer patients were not randomised in the main clinical trial
Kim 2005 No clinical data
Kleinkort 2005 Non-randomised study, not cancer related pain
Lamer 1994 No clinical data
Lange 1995 No clinical data
Librach 1988 No clinical data
Long 1991 No clinical data
McCaffery 1992 No clinical data
Miguel 2000 No clinical data
Naveau 1992 Acute, not chronic treatment-related pain
Oosterwijk 1994 No clinical data
Ostrowski 1979 Non-randomised study
Pan 2000 No clinical data
Patt 1990 No clinical data
Patt 1992 No clinical data
Picaza 1975 Non-randomised study, not cancer related pain
Rafter 1986 Not an RCT
Reuss 1985 Non-randomised study
Robb 2003 No clinical data
Robb 2004 No clinical data
Rutkowski 1980 Non-randomised study
Sang 2003 Non-randomised study
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(Continued)
Sharp 2003 No clinical data
Sloan 2004 No clinical data
Tonkin 1998 No clinical data
Urba 1996 No clinical data
Ventafridda 1979 Non-randomised study
Weinstein 1994 No clinical data
Wen 1977 Non-randomised study
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D A T A A N D A N A L Y S E S
This review has no analyses.
A P P E N D I C E S
Appendix 1. MEDLINE search strategy
MEDLINE search (1950 to present) (April 2008) - via Dialog Datastar:
1. TRANSCUTANEOUS ADJ ELECTRIC ADJ NERVE ADJ STIMULATION
2. TRANSCUTANEOUS-ELECTRIC-NERVE-STIMULATION.DE.
3. TNS
4. PERCUTANEOUS ADJ ELECTRIC ADJ NERVE ADJ STIMULATION
5. ELECTRIC ADJ STIMULATION ADJ THERAPY
6. ELECTRIC-STIMULATION-THERAPY.DE.

















24. 17 OR 18 OR 19 OR 20 OR 21 OR 22 OR 23
25. PAIN$
26. PAIN#.W..DE.
27. PAIN ADJ MEASUREMENT
28. PAIN-MEASUREMENT.DE.
29. PAIN ADJ SCALE
30. 25 OR 26 OR 27 OR 28 OR 29
31. 16 AND 24 AND 30
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Appendix 2. Other search strategies
1 CINAHL search (1982 to 2008)
Search terms




5. ELECTRIC ADJ STIMULATION ADJ THERAPY
6. PERCUTANEOUS ADJ ELECTRIC ADJ NERVE ADJ STIMULATION










17. 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14 OR 15 OR 16
18. CANCER
19. CANCER-PATIENTS.DE.
20. CANCER ADJ PAIN
21. CANCER-PAIN.DE.
22. NEOPLASM
15Transcutaneous electric nerve stimulation (TENS) for cancer pain in adults (Review)









30. 18 OR 19 OR 20 OR 21 OR 22 OR 23 OR 24 OR 25 OR 26 OR 27 OR 28 OR 29
31. PAIN
32. PAIN#.W..DE.
33. PAIN ADJ MEASUREMENT
34. PAIN-MEASUREMENT.DE.
35. PAIN ADJ SCALE
36. 31 OR 32 OR 33 OR 34 OR 35
37. ADULT.DE. OR MIDDLE-AGE OR AGED.W..DE. OR AGED-80-AND-OVER
38. CLINICAL ADJ TRIAL




43. RANDOMISED ADJ CONTROLLED ADJ TRIAL
44. VALIDATION
45. RANDOM ADJ ALLOCATION
46. EXPERIMENTAL-STUDIES#.DE. OR CLINICAL-TRIALS#.DE.
47. CLINICAL ADJ RESEARCH
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(Continued)
48. CLINICAL-RESEARCH#.DE.
49. 38 OR 39 OR 40 OR 41 OR 42 OR 43 OR 44 OR 45 OR 46 OR 47 OR 48
50. 17 AND 30 AND 36
51. 17 AND 30 AND 36 AND 49
52. 51 AND 37
2 EMBASE Search (1974 to 2008)
Search terms
1. TRANSCUTANEOUS ADJ ELECTRIC ADJ NERVE ADJ STIMULATION
2. TRANSCUTANEOUS-NERVE-STIMULATION.DE.
3. TNS
4. PERCUTANEOUS ADJ ELECTRIC ADJ NERVE ADJ STIMULATION
5. ELECTROSTIMULATION.W..DE.
6. ELECTRIC ADJ STIMULATION ADJ THERAPY
7. ELECTROSTIMULATION-THERAPY.DE. OR NERVE-STIMULATION#.DE.
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(Continued)











28. 18 OR 19 OR 20 OR 21 OR 22 OR 23 OR 24 OR 25 OR 26 OR 27
29. PAIN
30. PAIN#.W..DE.
31. PAIN ADJ MEASUREMENT
32. PAIN-ASSESSMENT#.DE.
33. PAIN ADJ SCALE
34. 29 OR 30 OR 31 OR 32 OR 33
35. CLINICAL-TRIAL#
36. META-ANALYSIS.DE.
37. CLINICAL ADJ TRIAL
38. CONTROLLED ADJ CLINICAL ADJ TRIAL
39. RANDOMISED ADJ CONTROLLED ADJ TRIAL
40. META-ANALYSIS
41. EVIDENCE-BASED-PRACTICE#.DE.
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44. RANDOM ADJ ALLOCATION
45. MEDICAL-RESEARCH#.DE.
46. CLINICAL ADJ RESEARCH
47. CLINICAL-RESEARCH.DE.
48. 35 OR 36 OR 37 OR 38 OR 39 OR 40 OR 41 OR 42 OR 43 OR 44 OR 45 OR 46 OR 47
49. 17 AND 28 AND 34
50. 48 AND 49
51. ADULT# OR AGED.DE.
52. 50 AND 51
3 AMED Search (1985 to 2008)
search terms
1. TRANSCUTANEOUS ADJ ELECTRIC ADJ NERVE ADJ STIMULATION
2. TRANSCUTANEOUS-NERVE-STIMULATION.DE.
3. TNS
4. PERCUTANEOUS ADJ ELECTRIC ADJ NERVE ADJ STIMULATION
5. ELECTROSTIMULATION.W..DE.
6. ELECTRIC ADJ STIMULATION ADJ THERAPY
7. ELECTROSTIMULATION-THERAPY.DE. OR NERVE-STIMULATION#.DE.
8. ELECTRIC ADJ STIMULATION
9. ELECTROANALGESI$
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28. 18 OR 19 OR 20 OR 21 OR 22 OR 23 OR 24 OR 25 OR 26 OR 27
29. PAIN
30. PAIN#.W..DE.
31. PAIN ADJ MEASUREMENT
32. PAIN-ASSESSMENT#.DE.
33. PAIN ADJ SCALE
34. 29 OR 30 OR 31 OR 32 OR 33
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37. CLINICAL ADJ TRIAL
38. CONTROLLED ADJ CLINICAL ADJ TRIAL





44. RANDOM ADJ ALLOCATION
45. MEDICAL-RESEARCH#.DE.
46. CLINICAL ADJ RESEARCH
47. CLINICAL-RESEARCH.DE.
48. 35 OR 36 OR 37 OR 38 OR 39 OR 40 OR 41 OR 42 OR 43 OR 44 OR 45 OR 46 OR 47
49. 17 AND 28 AND 34
50. 48 AND 49
51. ADULT# OR AGED.DE.
52. 50 AND 51
4 Search of The Cochrane Library
Search terms
In addition, Cochrane search history (Reviews / CENTRAL / DARE):
1.Transcutaneous electric nerve stimulation (All fields & products)
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(Continued)
2.MeSH descriptor TENS, this term only in MeSH products
3.Cancer (All fields & products)
4.MeSH descriptor Neoplasms (explode all trees)
5.Pain (All fields & products)
6.MeSH descriptor Pain (explode all trees)
7.(#1 or #2) and (#3 or #4) and (#5 or #6)
WH A T ’ S N E W
Last assessed as up-to-date: 20 April 2008.
21 April 2008 Amended Converted to new review format.
H I S T O R Y
Protocol first published: Issue 4, 2006
Review first published: Issue 3, 2008
18 March 2008 New citation required and conclusions have changed Substantive amendment
22Transcutaneous electric nerve stimulation (TENS) for cancer pain in adults (Review)
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.




Search strategy: SO, KR
Paper collection: HR
Review of studies (appraisal/quality/data extraction): KS, MB, MJ, SO
Statistical analysis: SO, KR, MB, MJ, KS
Discussion: All
Final production: KR
Contact for Cochrane: KR
Group co-ordinator: SO, KR
D E C L A R A T I O N S O F I N T E R E S T
Karen Robb is lead author of one of the included studies in this review.
S O U R C E S O F S U P P O R T
Internal sources
• Barts and the London NHS Trust and Tower Hamlets PCT, UK.
External sources
• No sources of support supplied
I N D E X T E R M S
Medical Subject Headings (MeSH)
Neoplasms [∗complications]; Pain [etiology; ∗therapy]; Randomized Controlled Trials as Topic; Transcutaneous Electric Nerve Stim-
ulation [∗methods]
23Transcutaneous electric nerve stimulation (TENS) for cancer pain in adults (Review)
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
MeSH check words
Adult; Humans
24Transcutaneous electric nerve stimulation (TENS) for cancer pain in adults (Review)
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
